New treatment option for Lung Trauma
Official title Effects of Non-invasive Ventilation Therapies on the Lung in Hypoxemic Chest Trauma Patients
ClinicalTrials.gov ID: NCT06735872
What this study is testing
- What it's testing
- Chest trauma is common in traumatology. Its management is based on ventilatory therapies, among which non-invasive ventilation (NIV) is commonly used.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age \> 18 years old
- Chest trauma \< 5 days
- At least 3 ribs fracture on initial CT-scan
- Need of oxygen moderated to maintain monitoring oxygen saturation Sp02 \> 92% or partial pressure of arterial oxygen Pa02/ Fraction of inspired...
- Intensive Care Unit admission
You likely can't join if
- Patient intubated or with respiratory failure : measured or estimated Pa02/FiO2 \ 35/min, abundant tracheal secretions, significant increase in work...
- Inability to maintain 10 seconds of apnoea required for scan acquisition
- Patient treated with ventilatory support by NIV or HFO in the 12 hours prior the investigation
- Uncontrolled circulatory failure with need for introduction of Noradrenaline \> 0,15 ug/kg/min
- Uncontrolled neurological failure with Glasgow Coma Scale (CGS \< 15
- Unstable facial trauma or with pneumocephalus or basilar skull trauma
See the full eligibility criteria
- Age \> 18 years old
- Chest trauma \< 5 days
- At least 3 ribs fracture on initial CT-scan
- Need of oxygen moderated to maintain monitoring oxygen saturation Sp02 \> 92% or partial pressure of arterial oxygen Pa02/ Fraction of inspired oxygen FiO2 \> 200
- Intensive Care Unit admission
- Need a chest CT control during the five first days after the trauma
- Patient intubated or with respiratory failure : measured or estimated Pa02/FiO2 \ 35/min, abundant tracheal secretions, significant increase in work of accessory respiratory muscles on inspiration, signs of respiratory...
- Inability to maintain 10 seconds of apnoea required for scan acquisition
- Patient treated with ventilatory support by NIV or HFO in the 12 hours prior the investigation
- Uncontrolled circulatory failure with need for introduction of Noradrenaline \> 0,15 ug/kg/min
- Uncontrolled neurological failure with Glasgow Coma Scale (CGS \< 15
- Unstable facial trauma or with pneumocephalus or basilar skull trauma
- Large, undrained pneumothorax with lateral separation at the level of the hilum \> 2 cm and extensive throughout the axillary line
- Patients with identified cognitive impairment
- Persons deprived of liberty, persons under protective measures
- Persons not affiliated to a social security insurance
- Current pregnancy or breastfeeding
- Refusal to participate in the study
The study team makes the final eligibility decision.
Where it's taking place
- Lyon, Rhône, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lyon, Rhône, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.